Reimagining Medicine Q2 2023 Results slide image

Reimagining Medicine Q2 2023 Results

Company overview Financial review Conclusions Appendix References Vas Narasimhan, M.D. Chief Executive Officer 27 Investor Relations | Q2 2023 Results NOVARTIS | Reimagining Medicine
View entire presentation